Invest in Bala Enzyme - Doctor-formulated inflammation relief with turmeric and all-natural ingredients
Bala Enzyme is the first doctor-formulated drink mix that combats both inflammation and dehydration using zero sugar and no artificial ingredients.
And the company is already making waves - with 2,000,000 packets sold, 100,000+ satisfied customers, $1.5M in cumulative sales, and an Amazon business growing rapidly at 69% year-over-year, Bala Enzyme is making a dent in the functional hydration market.
By combining the natural and potent anti-inflammatory properties of certain plant enzymes, Bala Enzyme's founders created a proprietary formula (EnzymX Recovery Accelerator® - patent pending) that is deeply rooted in science with demonstrated results for providing relief and recovery.
Founded by two doctors who have committed their careers to helping others heal, and backed by a team of CPG experts with multiple successful exits, Bala is uniquely positioned to disrupt the $180B functional hydration market.
Bala Enzyme's leadership team is complemented by some of the top minds in foods and beverages with investors, advisors, and board members bringing crucial insights from companies like Poppi, Coca-Cola, Vitamin Water, and Vita Coco.
Bala Enzyme has sold products to 100,000+ happy customers, generated $1.5M in cumulative sales, and can be found in retailers across the country.
Bala Enzyme is especially proud of what it has been able to achieve online, as its average customer acquisition cost (CAC) is incredibly low compared to its lifetime customer value (LTV), reflecting that subscribers are with them for a long time.
Online sales accounted for 70% of revenue in 2024. This is also the most profitable channel with sales on Amazon growing quickly, up 69% over the past year.
Bala Enzyme is hyper-focused on growing subscriptions and returning customers, driven by their digital store which simplifies reordering and builds customer loyalty. Today 35% of their online orders are from repeat customers and 45% of our revenue comes via subscriptions.
While the digital channel is growing, expanding retail is critical. Physical shelf-space lets them showcase products and build brand equity - greatly complementing their online strategy.
And their channel expansion strategy is well underway: They're already in 2,000 natural grocery retailers, and are at a critical inflection point: major conventional grocery chains like Kroger, Publix, Target, and Whole Foods Market are reviewing Bala for nationwide placement.
But their vision goes beyond natural grocery retailers - targeting the massive club channel with retailers like Costco and the extensive drug channel with chains like CVS, which alone has over 9,000 stores nationwide. If they're able to land just a couple of these retailers, it’ll be game-changing in terms of revenue acceleration.
Higher volumes will drive more efficient economies of scale – lower production costs, reduced shipping expenses, and decreased overhead – which they expect will increase their gross margin from 59% to 71% by 2029.
They expect retail to eventually constitute a majority of their revenue. Part of their sales will be fueled by new product launches and they've got a number of exciting releases in the pipeline.
Bala Enzyme has several new innovations in the pipeline, including new product formats such as capsules and gummies to complement their existing portfolio. Even more exciting, they've developed new enzyme formulations targeting immune support and brain health – high-growth markets with substantial consumer demand and currently limited competition. These extensions leverage their scientific expertise while expanding their reach into complementary wellness categories.
The functional beverage acquisition market is HOT - but it won't stay that way. Major beverage giants like PepsiCo and Unilever are aggressively acquiring innovative brands, with Poppi commanding $1.95B and Liquid I.V. $500M. These companies are strategically filling limited category slots in their portfolios. The time to act is NOW.
Investment Start Date: May 19, 2025
Investment End Date: December 31, 2025
Your investment helps accelerate Bala's expansion - by scaling their retail footprint, launching their immunity line, and expanding online sales, you're securing a position in what could be the next major functional beverage acquisition.
Bala sits at the powerful intersection of science-backed wellness and real human needs. Their patent-pending formula, passionate customer base, and expanding retail presence have positioned them for extraordinary growth.
This is your chance to be part of a true wellness revolution - a movement that's changing how people recover, rehydrate, and thrive every day.
Learn more here: https://wefunder.com/balaenzyme/
Disclaimer: This post is for informational purposes only and isn't financial advice. We're not financial advisors. All investments carry risks, especially startup companies. Always do your own research and consult with a financial professional before investing. For more information contact the company and do your own due diligence.